133 related articles for article (PubMed ID: 8081854)
1. Conformationally restricted analogues of the potent CCK-B antagonist CI-988.
Higginbottom M; Hill DR; Horwell DC; Mostafai E; Suman-Chauhan N; Roberts E
Bioorg Med Chem; 1993 Sep; 1(3):209-17. PubMed ID: 8081854
[TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin B antagonists. Synthesis and quantitative structure-activity relationships of a series of C-terminal analogues of CI-988.
Augelli-Szafran CE; Horwell DC; Kneen C; Ortwine DF; Pritchard MC; Purchase TS; Roth BD; Trivedi BK; Hill D; Suman-Chauhan N; Webdale L
Bioorg Med Chem; 1996 Oct; 4(10):1733-45. PubMed ID: 8931944
[TBL] [Abstract][Full Text] [Related]
3. Highly constrained dipeptoid analogues containing a type II' beta-turn mimic as novel and selective CCK-A receptor ligands.
de la Figuera N; Martín-Martínez M; Herranz R; García-López MT; Latorre M; Cenarruzabeitia E; del Río J; González-Muñiz R
Bioorg Med Chem Lett; 1999 Jan; 9(1):43-8. PubMed ID: 9990454
[TBL] [Abstract][Full Text] [Related]
4. Development of CCK-B antagonists.
Horwell DC
Neuropeptides; 1991 Jul; 19 Suppl():57-64. PubMed ID: 1881533
[TBL] [Abstract][Full Text] [Related]
5. beta-Turned dipeptoids as potent and selective CCK(1) receptor antagonists.
Martín-Martínez M; De La Figuera N; Latorre M; Herranz R; García-López MT; Cenarruzabeitia E; Del Río J; González-Muñiz R
J Med Chem; 2000 Oct; 43(20):3770-7. PubMed ID: 11020292
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and receptor binding affinity of cholecystokinin receptor ligands: 2-and 1-indolyl derivatives of PD134308.
Araldi G; Donati D; Oliosi B; Ursini A; van Amsterdam F; Natalini B; Pellicciari R; Tarzia G
Farmaco; 1996 Jul; 51(7):471-6. PubMed ID: 8765669
[TBL] [Abstract][Full Text] [Related]
7. Rationally designed "dipeptoid" analogues of CCK. Acid mimics of the potent and selective non-peptide CCK-B receptor antagonist CI-988.
Drysdale MJ; Pritchard MC; Horwell DC
J Med Chem; 1992 Jul; 35(14):2573-81. PubMed ID: 1635058
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and SAR of new 5-phenyl-3-ureido-1,5-benzodiazepines as cholecystokinin-B receptor antagonists.
Ursini A; Capelli AM; Carr RA; Cassarà P; Corsi M; Curcuruto O; Curotto G; Dal Cin M; Davalli S; Donati D; Feriani A; Finch H; Finizia G; Gaviraghi G; Marien M; Pentassuglia G; Polinelli S; Ratti E; Reggiani AM; Tarzia G; Tedesco G; Tranquillini ME; Trist DG; Van Amsterdam FT
J Med Chem; 2000 Oct; 43(20):3596-613. PubMed ID: 11020274
[TBL] [Abstract][Full Text] [Related]
9. 5-(Tryptophyl)amino-1,3-dioxoperhydropyrido[1,2-c]pyrimidine-based potent and selective CCK(1) receptor antagonists: structure-activity relationship studies on the central 1,3-dioxoperhydropyrido[1,2-c]pyrimidine scaffold.
Bartolomé-Nebreda JM; García-López MT; González-Muñiz R; Cenarruzabeitia E; Latorre M; Del Río J; Herranz R
J Med Chem; 2001 Nov; 44(24):4196-206. PubMed ID: 11708921
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the behaviour of selected CCKB/gastrin receptor antagonists in radioligand binding assays performed in mouse and rat cerebral cortex.
Harper EA; Griffin EP; Shankley NP; Black JW
Br J Pharmacol; 1999 Mar; 126(6):1496-503. PubMed ID: 10217545
[TBL] [Abstract][Full Text] [Related]
11. Role of N- and C-terminal substituents on the CCK-B agonist-antagonist pharmacological profile of Boc-Trp-Phg-Asp-Nal-NH2 derivatives.
Weng JH; Blommaert AG; Moizo L; Bado A; Ducos B; Böhme A; Garbay C; Roques BP
Bioorg Med Chem; 1996 Apr; 4(4):563-73. PubMed ID: 8735845
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in the chemistry of cholecystokinin receptor ligands (agonists and antagonists).
de Tullio P; Delarge J; Pirotte B
Curr Med Chem; 1999 Jun; 6(6):433-55. PubMed ID: 10213792
[TBL] [Abstract][Full Text] [Related]
13. Dual CCK-A and CCK-B receptor antagonists (II). Preparation and structure activity relationships of 5-alkyl-9-methyl-1,4-benzodiazepines and discovery of FR208419.
Tabuchi S; Ito H; Sogabe H; Kuno M; Kinoshita T; Katumi I; Yamamoto N; Mitsui H; Satoh Y
Chem Pharm Bull (Tokyo); 2000 Jan; 48(1):1-15. PubMed ID: 10705468
[TBL] [Abstract][Full Text] [Related]
14. 'Targeted' molecular diversity: design and development of non-peptide antagonists for cholecystokinin and tachykinin receptors.
Horwell D; Pritchard M; Raphy J; Ratcliffe G
Immunopharmacology; 1996 Jun; 33(1-3):68-72. PubMed ID: 8856117
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and stereochemical structure-activity relationships of 1,3-dioxoperhydropyrido[1,2-c]pyrimidine derivatives: potent and selective cholecystokinin-A receptor antagonists.
Martín-Martínez M; Bartolomé-Nebreda JM; Gómez-Monterrey I; González-Muñiz R; García-López MT; Ballaz S; Barber A; Fortuño A; Del Río J; Herranz R
J Med Chem; 1997 Oct; 40(21):3402-7. PubMed ID: 9341915
[TBL] [Abstract][Full Text] [Related]
16. Modification of receptor selectivity and functional activity in cholecystokinin peptoid ligands.
Dezube M; Sugg EE; Birkemo LS; Croom DK; Dougherty RW; Ervin GN; Grizzle MK; James MK; Johnson MF; Mosher JT
J Med Chem; 1995 Aug; 38(17):3384-90. PubMed ID: 7650691
[TBL] [Abstract][Full Text] [Related]
17. Novel constrained CCK-B dipeptoid antagonists derived from pipecolic acid.
Bellier B; Da Nascimento S; Meudal H; Gincel E; Roques BP; Garbay C
Bioorg Med Chem Lett; 1998 Jun; 8(11):1419-24. PubMed ID: 9871777
[TBL] [Abstract][Full Text] [Related]
18. Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity.
Hughes J; Boden P; Costall B; Domeney A; Kelly E; Horwell DC; Hunter JC; Pinnock RD; Woodruff GN
Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6728-32. PubMed ID: 1975695
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.
Nishida A; Miyata K; Tsutsumi R; Yuki H; Akuzawa S; Kobayashi A; Kamato T; Ito H; Yamano M; Katuyama Y
J Pharmacol Exp Ther; 1994 May; 269(2):725-31. PubMed ID: 7910212
[TBL] [Abstract][Full Text] [Related]
20. Nonpeptide cholecystokinin-2 receptor agonists.
Kalindjian SB; Dunstone DJ; Low CM; Pether MJ; Roberts SP; Tozer MJ; Watt GF; Shankley NP
J Med Chem; 2001 Apr; 44(8):1125-33. PubMed ID: 11312913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
